Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06055439 |
|---|---|
| Brief Title: | A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy |
| First Submitted : | September 13, 2023 |
| First Submitted that Met QC Criteria : | September 20, 2023 |
| First Posted : | September 26, 2023 |
| Last Update Submitted that Met QC Criteria : | January 16, 2024 |
| Last Update Posted : | January 18, 2024 |